Breast Cancer

New Drug May Rival Tamoxifen

Published in Women's Health Weekly, June 8th, 2000

Researchers say they've shown a cheaper new drug might rival the breast cancer drug tamoxifen, giving women more options in their treatment.

The drug, Fareston, marketed by Kentucky-based Shire Roberts under the generic name toremifene, is in the same class as tamoxifen.

A trial of 899 patients showed the two drugs worked about equally in women past menopause who had undergone surgery for the same stage of breast cancer. The patients were followed for a little over three years on average.

"The results of this study are of significant importance because they show that Fareston is as effective as tamoxifen in the adjuvant...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2000-06-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry